The bonds will be issued by Biocon Biologics Global plc which is a wholly owned subsidiary of BBL and will be backed by a strong security package, the company said.
Anthropic pre-IPO credit facility set to climb past $10 billion
Anthropic is broadening its revolving credit facility past the initial target to prepare for its much-anticipated initial public offering. Multiple banks are looking to partake